Literature DB >> 11747013

0.5 M Gd chelate (Magnevist) versus 1.0 M Gd chelate (Gadovist): dose-independent effect on image quality of pelvic three-dimensional MR-angiography.

M Goyen1, T C Lauenstein, C U Herborn, J F Debatin, S Bosk, S G Ruehm.   

Abstract

To compare the effect on image quality of a 1.0 M gadolinium (Gd) chelate to that of a conventional 0.5 M Gd chelate, five healthy volunteers and seven patients with angiographically documented aorto-iliac disease underwent a mono-station three-dimensional magnetic resonance angiography (MRA) exam (Siemens SONATA, Erlangen, Germany) twice, once using Gadovist 1.0 and the other time using Magnevist as the contrast agent. All subjects received a fixed volume of Gadovist 1.0, corresponding to a dose between 0.1 and 0.15 mmol/kg body weight followed by a saline flush. For the Magnevist exam, the contrast agent volumes and flow rates were doubled. For both quantitative and qualitative analysis of the angiographic data sets, the arterial tree was divided into nine segments. 1 M Gadovist 1.0-enhanced three-dimensional MRA data sets were characterized by significantly higher signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) values compared to 0.5 M Magnevist-enhanced images. The data revealed mean SNR/CNR increases exceeding 70% (P < 0.01). Although there was no statistically significant difference in the rating of image quality (P > 0.05), the Gadovist 1.0 exam led to better delineation of the arterial morphology, especially of small vessels. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747013     DOI: 10.1002/jmri.1225

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  20 in total

1.  Contrast media in magnetic resonance angiography.

Authors:  Georg M Bongartz
Journal:  Eur Radiol       Date:  2003-09       Impact factor: 5.315

Review 2.  Magnetic resonance cardiac perfusion imaging-a clinical perspective.

Authors:  Peter Hunold; Thomas Schlosser; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2006-05-03       Impact factor: 5.315

Review 3.  Cross-sectional vascular imaging with CT and MR angiography.

Authors:  Hasan K Kabul; Klaus D Hagspiel
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

4.  Assessment of the abdominal aorta and its visceral branches by contrast-enhanced dynamic volumetric hepatic parallel magnetic resonance imaging: feasibility, reliability and accuracy.

Authors:  Robert Werder; Daniel Nanz; Amelie M Lutz; Dominik Weishaupt; Lucas McCormack; Burkhardt Seifert; Borut Marincek; Jürgen K Willmann
Journal:  Eur Radiol       Date:  2006-09-01       Impact factor: 5.315

5.  Intra-individual, randomised comparison of the MRI contrast agents gadobutrol and gadoterate in imaging the distal lower limb of patients with known or suspected osteomyelitis, evaluated in an off-site blinded read.

Authors:  Werner Pennekamp; Daniela Roggenland; Steffen Hering; Stefan Lemburg; Soeren Peters; Sabrina Sterl; Carsten Schwenke; Volkmar Nicolas
Journal:  Eur Radiol       Date:  2010-12-21       Impact factor: 5.315

Review 6.  High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review.

Authors:  Frederik L Giesel; Amit Mehndiratta; Marco Essig
Journal:  Eur Radiol       Date:  2010-06-23       Impact factor: 5.315

7.  Assessment of the kidneys: magnetic resonance angiography, perfusion and diffusion.

Authors:  Ulrike I Attenberger; John N Morelli; Stefan O Schoenberg; Henrik J Michaely
Journal:  J Cardiovasc Magn Reson       Date:  2011-11-15       Impact factor: 5.364

8.  Intra-individual, randomised comparison of the MRI contrast agents gadobutrol versus gadoteridol in patients with primary and secondary brain tumours, evaluated in a blinded read.

Authors:  M Koenig; G Schulte-Altedorneburg; M Piontek; A Hentsch; P Spangenberg; C Schwenke; A Harders; L Heuser
Journal:  Eur Radiol       Date:  2013-07-04       Impact factor: 5.315

9.  Three-dimensional contrast-enhanced magnetic-resonance angiography of the renal arteries: interindividual comparison of 0.2 mmol/kg gadobutrol at 1.5 T and 0.1 mmol/kg gadobenate dimeglumine at 3.0 T.

Authors:  Ulrike I Attenberger; Henrik J Michaely; Bernd J Wintersperger; Steven P Sourbron; Klaus-Peter Lodemann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Eur Radiol       Date:  2008-02-16       Impact factor: 5.315

10.  Comparison between a linear versus a macrocyclic contrast agent for whole body MR angiography in a clinical routine setting.

Authors:  Achim Seeger; Ulrich Kramer; Michael Fenchel; Florian Grimm; Christiane Bretschneider; Jörg Döring; Bernhard Klumpp; Gunnar Tepe; Kilian Rittig; Peter R Seidensticker; Claus D Claussen; Stephan Miller
Journal:  J Cardiovasc Magn Reson       Date:  2008-12-30       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.